298 GENES FOUND

? »

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FGF2Fibroblast growth factor 2 (basic)Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
RAS pathway related proteins
Mixed
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
FTLFerritin, light polypeptideCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Expressed in all
GAAGlucosidase, alpha; acidDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GABRDGamma-aminobutyric acid (GABA) A receptor, deltaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GARTPhosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
GGPS1Geranylgeranyl diphosphate synthase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GLP2RGlucagon-like peptide 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
GLRA2Glycine receptor, alpha 2FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
GRIA1Glutamate receptor, ionotropic, AMPA 1FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enriched
GRIN2AGlutamate receptor, ionotropic, N-methyl D-aspartate 2ADisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
GSRGlutathione reductaseCancer-related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
GSSGlutathione synthetaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HBA1Hemoglobin, alpha 1Disease related genes
FDA approved drug targets
Plasma proteins
Tissue enriched
HBA2Hemoglobin, alpha 2Disease related genes
FDA approved drug targets
Plasma proteins
Tissue enriched
HBBHemoglobin, betaDisease related genes
FDA approved drug targets
Plasma proteins
Tissue enriched
HDAC1Histone deacetylase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC2Histone deacetylase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC3Histone deacetylase 3Enzymes
FDA approved drug targets
Expressed in all
HDAC6Histone deacetylase 6Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
HDAC9Histone deacetylase 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
HMMRHyaluronan-mediated motility receptor (RHAMM)CD markers
FDA approved drug targets
Mixed
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Group enriched
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HRH1Histamine receptor H1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
HTR75-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
IL2RAInterleukin 2 receptor, alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor, gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
IMPDH2IMP (inosine 5'-monophosphate) dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Expressed in all
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all

« prev | Page of 6 | next »